Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer. [electronic resource]
- International journal of radiation oncology, biology, physics Jun 2008
- 407-13 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
0360-3016
10.1016/j.ijrobp.2007.10.011 doi
Aged Aged, 80 and over Antineoplastic Agents, Phytogenic--administration & dosage Carcinoma, Non-Small-Cell Lung--drug therapy Female Humans Lung Neoplasms--drug therapy Male Middle Aged Paclitaxel--administration & dosage Radiation-Sensitizing Agents--administration & dosage